000			02042 a2200529 4500
005			20250515174554.0
264		0	_c20090720
008			200907s 0 0 eng d
022			_a1532-1827
024	7		_a10.1038/sj.bjc.6605134 _2doi
040			_aNLM _beng _cNLM
100	1		_aKweekel, D M
245	0	0	_aExplorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array. _h[electronic resource]
260			_bBritish journal of cancer _cJul 2009
300			_a357-62 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAntineoplastic Agents _xadverse effects
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aAtaxia Telangiectasia Mutated Proteins
650	0	4	_aCamptothecin _xadministration & dosage
650	0	4	_aCapecitabine
650	0	4	_aCell Cycle Proteins _xgenetics
650	0	4	_aColorectal Neoplasms _xdrug therapy
650	0	4	_aDNA Repair _xgenetics
650	0	4	_aDNA, Neoplasm _xblood
650	0	4	_aDNA-Binding Proteins _xgenetics
650	0	4	_aDeoxycytidine _xadministration & dosage
650	0	4	_aDisease-Free Survival
650	0	4	_aEndonucleases _xgenetics
650	0	4	_aFluorouracil _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aIrinotecan
650	0	4	_aNuclear Proteins _xgenetics
650	0	4	_aOrganoplatinum Compounds _xadministration & dosage
650	0	4	_aOxaliplatin
650	0	4	_aPolymorphism, Single Nucleotide
650	0	4	_aProtein Serine-Threonine Kinases _xgenetics
650	0	4	_aTranscription Factors _xgenetics
650	0	4	_aTumor Suppressor Proteins _xgenetics
700	1		_aAntonini, N F
700	1		_aNortier, J W R
700	1		_aPunt, C J A
700	1		_aGelderblom, H
700	1		_aGuchelaar, H-J
773	0		_tBritish journal of cancer _gvol. 101 _gno. 2 _gp. 357-62
856	4	0	_uhttps://doi.org/10.1038/sj.bjc.6605134 _zAvailable from publisher's website
999			_c18954482 _d18954482